Kurtz 1981
| Methods | RCT: enrolled: 309 evaluated: 255 | |
| Participants | Inclusion: 1. Cancer patients with positive isotope brain scans 2. No evidence of disseminated disease Exclusion: 1. NFC IV 2. Anti‐cancer treatment within previous 2 wks 3. Progressive untreated primary | |
| Interventions | 5000 cGy/20 fr versus 3000 cGy/10 fr | |
| Outcomes | 1. Survival 2. Median time to progression 3. Palliation of symptoms (4. Improvement rate) (5. Cause of death) | |
| Notes | QS = 3 | |